• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疟疾疫苗:是成功还是磨难?

Malaria vaccines: triumphs or tribulations?

作者信息

Ballou W R, Kester K E, Stoute J A, Heppner D G

机构信息

Department of Immunology, Walter Reed Army Institute of Research, Washington, DC 20307-5100, USA.

出版信息

Parassitologia. 1999 Sep;41(1-3):403-8.

PMID:10697893
Abstract

A safe and effective malaria vaccine will greatly facilitate efforts to control the global spread of malaria. This paper discusses the conceptual framework for developing malaria vaccines and some of the difficulties that the various approaches face. It emphasizes the role of pre-erythrocytic malaria vaccines, which are designed to protect against malaria infection, rather than simply prevent clinical disease. It describes recent encouraging results in human subjects with the RTS,S vaccine, a promising pre-erythrocytic malaria vaccine candidate.

摘要

一种安全有效的疟疾疫苗将极大地推动全球疟疾防控工作。本文讨论了开发疟疾疫苗的概念框架以及各种方法所面临的一些困难。它强调了针对疟原虫感染阶段的疟疾疫苗的作用,这类疫苗旨在预防疟疾感染,而非仅仅预防临床疾病。文中描述了在人体试验中使用RTS,S疫苗所取得的近期令人鼓舞的结果,RTS,S疫苗是一种很有前景的针对疟原虫感染阶段的疟疾疫苗候选产品。

相似文献

1
Malaria vaccines: triumphs or tribulations?疟疾疫苗:是成功还是磨难?
Parassitologia. 1999 Sep;41(1-3):403-8.
2
Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.迈向基于RTS,S的多阶段、多抗原恶性疟疫苗:沃尔特·里德陆军研究所的进展
Vaccine. 2005 Mar 18;23(17-18):2243-50. doi: 10.1016/j.vaccine.2005.01.142.
3
Pre-erythrocytic malaria vaccines: towards greater efficacy.红细胞前期疟疾疫苗:追求更高疗效。
Nat Rev Immunol. 2006 Jan;6(1):21-32. doi: 10.1038/nri1746.
4
RTS,S/AS02A for malaria.用于疟疾的RTS,S/AS02A疫苗。
Expert Rev Vaccines. 2006 Oct;5(5):611-5. doi: 10.1586/14760584.5.5.611.
5
[Achievements and perspectives of research into development of a vaccine against malaria].[疟疾疫苗研发的研究成果与展望]
Wiad Parazytol. 2010;56(2):133-40.
6
Malaria vaccines in development.正在研发的疟疾疫苗。
Expert Opin Emerg Drugs. 2005 Aug;10(3):489-503. doi: 10.1517/14728214.10.3.489.
7
Advances in vaccine development against the pre-erythrocytic stage of Plasmodium falciparum malaria.针对恶性疟原虫疟疾红细胞前期阶段疫苗研发的进展
Expert Rev Vaccines. 2006 Feb;5(1):81-93. doi: 10.1586/14760584.5.1.81.
8
Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS,S/AS02A.新型佐剂配方改善疟疾疫苗RTS,S/AS02A免疫原性的临床前评估
Vaccine. 2006 Oct 30;24(42-43):6483-92. doi: 10.1016/j.vaccine.2006.06.033. Epub 2006 Jul 3.
9
Safety and immunogenicty of RTS,S/AS02A candidate malaria vaccine in Gambian children.RTS,S/AS02A候选疟疾疫苗在冈比亚儿童中的安全性和免疫原性。
Vaccine. 2005 Jul 14;23(32):4148-57. doi: 10.1016/j.vaccine.2005.03.019. Epub 2005 Apr 15.
10
Plasmodium falciparum malaria vaccines in development.正在研发的恶性疟原虫疟疾疫苗。
Expert Rev Vaccines. 2008 Mar;7(2):223-40. doi: 10.1586/14760584.7.2.223.

引用本文的文献

1
Diversity oriented synthesis for novel anti-malarials.新型抗疟药物的多样性导向合成
Syst Synth Biol. 2015 Dec;9(Suppl 1):49-53. doi: 10.1007/s11693-015-9171-0. Epub 2015 May 10.
2
Diversity-oriented synthesis and activity evaluation of substituted bicyclic lactams as anti-malarial against Plasmodium falciparum.以多样性为导向的取代双环内酰胺作为抗恶性疟原虫疟疾药物的合成及活性评价
Malar J. 2014 Nov 28;13:467. doi: 10.1186/1475-2875-13-467.
3
Antibodies to malaria vaccine candidates are associated with chloroquine or sulphadoxine/pyrimethamine treatment efficacy in children in an endemic area of Burkina Faso.
在布基纳法索的一个疟疾流行地区,针对疟疾候选疫苗的抗体与氯喹或磺胺多辛/乙胺嘧啶治疗儿童的疗效有关。
Malar J. 2012 Mar 22;11:79. doi: 10.1186/1475-2875-11-79.
4
Measuring the effects of an ever-changing environment on malaria control.衡量不断变化的环境对疟疾控制的影响。
Infect Immun. 2004 Apr;72(4):2248-53. doi: 10.1128/IAI.72.4.2248-2253.2004.
5
Virus-like particles as vaccine adjuvants.病毒样颗粒作为疫苗佐剂。
Mol Biotechnol. 2001 Oct;19(2):169-77. doi: 10.1385/MB:19:2:169.
6
Antimalarial drugs clear resistant parasites from partially immune hosts.抗疟药物可清除部分免疫宿主中的耐药寄生虫。
Antimicrob Agents Chemother. 2001 Oct;45(10):2897-901. doi: 10.1128/AAC.45.10.2897-2901.2001.